ArticleNeuroendocrinology2022

Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.

Dieter Hörsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.